Molecular Diagnostics Conference
5 February 2025 | Room 2
Molecular Diagnostics Conference
Overview:
The Molecular Diagnostics track will delve into the cutting-edge advancements and innovative applications that are revolutionizing the field of diagnostics. As precision medicine continues to gain traction, this track will highlight the role of molecular diagnostics in enabling targeted therapies, early detection of diseases, and personalized patient care. Attendees will explore the latest technologies, including next-generation sequencing, liquid biopsy, and the integration of multi-omics approaches, all of which are shaping the future of diagnostics.
Key topics:
- Latest developments in Next Generation Sequencing (NGS) technologies and their clinical applications
- Exploring the expanding role of liquid biopsy in early diagnosis and real-time treatment monitoring
- Innovations in point-of-care molecular testing for real-time disease management
- How molecular diagnostics are shaping the future of pharmacogenomics and personalized medicine
- Clinical applications of Circulating Tumor DNA (ctDNA) in guiding treatment decisions and assessing minimal residual disease
Benefits of attending:
- Apply molecular diagnostics to personalize medicine and enhance treatment outcomes.
- Discover how molecular diagnostics are revolutionizing pharmacogenomics and tailored treatment plans;
- Stay updated on advancements in NGS, liquid biopsy, and multi-omics to improve diagnostic capabilities
Chair:
- Dr Imran Mirza, Consultant, Anatomical and Clinical Pathology, Chair, Clinical Pathology, National Reference Laboratory, Abu Dhabi,UAE
- Dr Taher Shabani, Chief Medical Officer, OncoHelix-CoLab in partnership with Burjeel Holdings, Abu Dhabi, UAE
